Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids.

Modolell M, Andreesen R, Pahlke W, Brugger U, Munder PG.

Cancer Res. 1979 Nov;39(11):4681-6.

2.

Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.

Vogler WR, Whigham E, Bennett WD, Olson AC.

Exp Hematol. 1985 Aug;13(7):629-33.

PMID:
3861326
3.

Purging murine leukemic marrow with alkyl-lysophospholipids.

Glasser L, Somberg LB, Vogler WR.

Blood. 1984 Dec;64(6):1288-91.

5.

Anti-tumor action of alkyl-lysophospholipids (Review).

Berdel WE, Bausert WR, Fink U, Rastetter J, Munder PG.

Anticancer Res. 1981;1(6):345-52. Review.

PMID:
7046622
6.

Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.

Berdel WE, Greiner E, Fink U, Stavrou D, Reichert A, Rastetter J, Hoffman DR, Snyder F.

Cancer Res. 1983 Feb;43(2):541-5.

PMID:
6848177
9.
10.

Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes.

Achterberg V, Gercken G.

Mol Biochem Parasitol. 1987 Mar;23(2):117-22.

PMID:
3574353
11.

Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.

Unger C, Eibl H, Kim DJ, Fleer EA, Kötting J, Bartsch HH, Nagel GA, Pfizenmaier K.

J Natl Cancer Inst. 1987 Feb;78(2):219-22.

PMID:
3468284
12.

Cell-destructive activity in the serum of a tumor patient after infusion of alkyl lysophospholipid.

Andreesen R, Munder PG.

J Natl Cancer Inst. 1983 Apr;70(4):623-7.

PMID:
6300501
13.

Studies on various parameters influencing leukemic cell destruction by alkyl-lysophospholipids.

Andreesen R, Modolell M, Oepke GH, Common H, Löhr GW, Munder PG.

Anticancer Res. 1982 Jan-Apr;2(1-2):95-100.

PMID:
7114806
14.
15.

Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.

Vogler WR, Olson AC, Okamoto S, Somberg LB, Glasser L.

Lipids. 1987 Nov;22(11):919-24.

PMID:
3328027
16.

Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties.

Houlihan WJ, Lee ML, Munder PG, Winslow CM, Cheon SH, D'Aries FJ, DeLillo AK, Jaeggi CS, Mason RB, Parrino VA.

J Lipid Mediat. 1990 Sep-Oct;2(5):295-307.

PMID:
2133273
17.

Selective destruction of human leukemic cells by alkyl-lysophospholipids.

Andreesen R, Modolell M, Weltzien HU, Eibl H, Common HH, Löhr GW, Munder PG.

Cancer Res. 1978 Nov;38(11 Pt 1):3894-9. No abstract available.

18.

Activation of macrophages by ether analogues of lysophospholipids.

Yamamoto N, Ngwenya BZ, Sery TW, Pieringer RA.

Cancer Immunol Immunother. 1987;25(3):185-92.

PMID:
2824051
19.

Destruction of human solid tumors by alkyl lysophospholipids.

Runge MH, Andreesen R, Pfleiderer A, Munder PG.

J Natl Cancer Inst. 1980 Jun;64(6):1301-6.

PMID:
6929370
20.

Alkyl-lysophospholipid induced suppression of human lymphocyte response to mitogens and selective killing of lymphoblasts.

Andreesen R, Modolell M, Weltzien HU, Munder PG.

Immunobiology. 1980 Jan;156(4-5):498-508.

PMID:
6445326

Supplemental Content

Support Center